| Literature DB >> 35535518 |
Molly F McGuire1, Bella Vakulenko-Lagun2, Michael B Millis3, Roi Almakias2, Earl P Cole4, Harry K W Kim1,5.
Abstract
AIMS: Perthes' disease is an uncommon hip disorder with limited data on the long-term outcomes in adulthood. We partnered with community-based foundations and utilized web-based survey methodology to develop the Adult Perthes Survey, which includes demographics, childhood and adult Perthes' disease history, the University of California Los Angeles (UCLA) Activity Scale item, Short Form-36, the Hip disability and Osteoarthritis Outcome Score, and a body pain diagram. Here we investigate the following questions: 1) what is the feasibility of obtaining > 1,000 survey responses from adults who had Perthes' disease using a web-based platform?; and 2) what are the baseline characteristics and demographic composition of our sample?Entities:
Keywords: Chi-squared tests; Hip Disability and Osteoarthritis Outcome Score; Legg-calve-perthes disease; Perthes disease; Short Form-36; Web-based survey; comorbidities; hip disorder; hip(s); obesity; physical therapy; total hip arthroplasty (THA)
Year: 2022 PMID: 35535518 PMCID: PMC9134832 DOI: 10.1302/2633-1462.35.BJO-2021-0185.R1
Source DB: PubMed Journal: Bone Jt Open ISSN: 2633-1462
Fig 1Facebook announcement from Perthes Kids Foundation Facebook group promoting the Adult Perthes Survey
Fig 2International Perthes Study Group website announcement and hyperlink for public to access the Adult Perthes Survey.
Fig 3Adult Perthes Survey enrolment, completion, and retention diagram. UCLA, University of California Los Angeles.
Testing relationship between Adult Perthes Survey completion and sex, age, country of residence, and language (n = 1,416).
| Variable | Complete respondents | Partial respondents | p-value |
|---|---|---|---|
| Age, continuous per five-year increase (OR; 95% CI) | 1.05 (0.99 to 1.11) | ||
|
| |||
| USA/Not USA (2 × 2 table) | 570 (USA) | 103 (USA) | 0.365 |
| USA/UK/Australia/Canada/Other (2 × 5 table) | - | - | 0.295 |
| Female, n | 685 | 134 | 0.903 |
| Language | 1,054 English | 203 English | 0.721 |
Complete respondents completed everything except for the body pain diagram; partial respondents only partially completed the survey (see Figure 3).
Chi-squared test.
English includes New Zealand, Australia, Canada, UK, USA.
CI, confidence interval; OR, odds ratio.
Sociodemographic distribution of characteristics of Adult Perthes Survey respondents (n = 1,182).
| Variable | Mean by sex (SD) | ||
|---|---|---|---|
| Male (n = 497) | Female (n = 685) | Total | |
| Age at time of survey, yrs | 40.7 (13) | 38.2 (12.3) | 39.3 (12.6) |
| BMI at time of survey, kg/m2
| 29 (6.9) | 30 (8.0) | 29.6 (7.6) |
There are a total of 200 missing values; the percentages are out of the non-missing.
New York, Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New England, New Jersey, Pennsylvania, Delaware, Maryland, District of Columbia.
Iowa, Kansas, Missouri, Nebraska, North Dakota, South Dakota, Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin.
Texas, Florida, Georgia, North Carolina, Virginia, Tennessee, Maryland, South Carolina, Alabama, Louisiana, Kentucky, Oklahoma, Arkansas, Mississippi, West Virginia.
Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming, Mountain, California, Washington, Oregon, Hawaii, Alaska, Pacific.
Fig 4Spearman’s rank-based correlation matrix of demographic and hip-specific data reported in the Adult Perthes Survey.
Childhood experience of Perthes’ disease by sex (n = 1,182).
| Variable | Frequencies by sex, n (%) | p-value | Total | |
|---|---|---|---|---|
| Male (n = 497) | Female (n = 685) | |||
| % bilateral | 73 (14.7) | 112 (16.4) | 0.487 | 185 (15.6) |
|
| 0.007 | |||
| Before turning 6 | 188 (37.8) | 324 (47.3) | 512 (43.3) | |
| Between 6 and 7 | 141 (28.4) | 180 (26.3) | 321 (27.2) | |
| Between 8 and 11 | 131 (26.4) | 130 (19) | 261 (22.1) | |
| After turning 11 | 33 (6.6) | 43 (6.3) | 76 (6.4) | |
|
| 0.489 | |||
| 0 | 307 (61.8) | 399 (58.2) | 706 (59.7) | |
| 1 | 61 (12.3) | 79 (11.5) | 140 (11.8) | |
| 2 | 71 (14.3) | 99 (14.4) | 170 (14.4) | |
| 3 | 30 (6) | 56 (8.2) | 86 (7.3) | |
| 4 | 13 (2.6) | 21 (3.1) | 34 (2.9) | |
| 5+ surgeries | 15 (3) | 31 (4.5) | 46 (3.9) | |
Chi-squared test.
Participants who reported treatment with surgery in Table IV did not necessarily report similarly in response to the item in Table III.
Childhood treatment experience of Perthes’ disease by country of residence (n = 1,182).
| Treatment type | Frequencies by country of residence, n (%) | |||
|---|---|---|---|---|
| USA | Non-USA | p-value | Total | |
| No treatment | 18 (3.2) | 57 (9.3) | < 0.001 | 75 (6.3) |
| Activity restrictions | 381 (66.8) | 371 (60.8) | 0.037 | 753 (63.7) |
| Walking device (walker, wheelchair, crutches) | 329 (57.7) | 311 (51) | 0.024 | 640 (54.1) |
| Weightbearing restrictions | 298 (52.3) | 262 (43) | 0.002 | 560 (47.4) |
| Physical therapy | 227 (39.8) | 254 (41.6) | 0.566 | 481 (40.7) |
| Surgery on either hip | 223 (39.1) | 254 (41.6) | 0.412 | 477 (40.4) |
| Bracing | 252 (44.2) | 143 (23.4) | < 0.001 | 395 (33.4) |
| Casting | 162 (28.4) | 184 (30.2) | 0.553 | 346 (29.3) |
| Traction | 23 (4) | 45 (7.4) | 0.020 | 68 (5.8) |
| Other | 20 (3.5) | 28 (4.6) | 0.428 | 48 (4.1) |
Two participants did not report their country of residence.
Chi-squared test.
Of two participants who did not report country of residence, one did report about activity restrictions, therefore the total is 753.
Participants who reported at least one surgery in Table III did not necessarily indicate they were treated with surgery in Table IV.
Adulthood treatments reported in the Adult Perthes Survey by sex (n = 1,182).
| Variable | Frequencies by sex, n (%) | |||
|---|---|---|---|---|
| Male (n = 497) | Female (n = 685) | p-value | Total | |
|
| 0.002 | |||
| 0 | 384 (77.3) | 451 (65.8) | 835 (70.6) | |
| 1 | 75 (15.1) | 147 (21.5) | 222 (18.8) | |
| 2 | 20 (4) | 44 (6.4) | 64 (5.4) | |
| 3 | 8 (1.6) | 21 (3.1) | 29 (2.5) | |
| 4 | 5 (1) | 10 (1.5) | 15 (1.3) | |
| 5+ surgeries | 5 (1) | 12 (1.7) | 17 (1.4) | |
|
| ||||
| Total hip arthroplasty | 89 (17.9) | 172 (25.1) | 0.004 | 261 (22.1) |
| Physical therapy | 47 (9.5) | 126 (18.4) | < 0.001 | 173 (14.6) |
| Arthroscopy | 17 (3.4) | 47 (6.9) | 0.014 | 64 (5.4) |
| Steroid injection | 8 (1.6) | 33 (4.8) | 0.005 | 41 (3.5) |
| Resurfacing | 9 (1.8) | 22 (3.2) | 0.193 | 31 (2.6) |
| Periacetabular osteotomy | 8 (1.6) | 18 (2.6) | 0.329 | 26 (2.2) |
| Surgical hip dislocation | 2 (0.4) | 12 (1.8) | 0.065 | 14 (1.2) |
| Other | 5 (1) | 14 (2) | 0.244 | 19 (1.6) |
| Unknown surgery | 19 (3.8) | 47 (6.9) | 0.034 | 66 (5.6) |
| Anticipating future surgery or revision (yes) | 213 (42.9) | 333 (48.6) | 0.843 | 546 (46.2) |
| Complications of total hip arthroplasty reported (yes) | 7 (7.9) | 7 (4.1) | 0.317 | 14 (5.4) |
Chi-squared test.
Fig 5Chronological survey response frequency from May 2019 to August 2020.